World-known Turkish-American heart surgeon Dr. Mehmet Oz especially stresses the fact that AI may tremendously increase corporations in the age of Turkiye. I have just had a chance to see Invamed, a major medical device manufacturer located in Ankara. Among the things I cannot forget were Professor Oz’s words on the superior capabilities of the company and the necessity to make efforts to keep competitive in global markets, keeping in mind the prospects of AI.
A hub of innovation and technology
Impamed, which is shipping its goods to more than 70 countries around the world, proves to be one of Turkiye’s strongest fields. Dr. Oz went through the complex manufacturing facility, where he had the opportunity to see the production of next-generation devices, such as heart valves, venous stents, and an AI-powered system for treating varicose veins. He was astounded by the tech-savvy nature and immense size of operations, which made him commend the company on its exceptional status in the international market to which Invamed belongs.
He asserted that after my tours outside of major research centers worldwide i had never seen such a smart capability situated anywhere else said Dr Oz. He pointed out the significance of mutual understanding between the company’s technicians and surgeons from every corner of the world to improve the product’s continuous evolution until its final form reaches worldwide verification.
Turkiye’s bright future in health technology
During a meeting with invamed president Adi Talep and scientists in the center Dr Oz dwelled upon the advantageous position of Turkey in biomedical technologies. By means of recognition of well-trained scientists and specific positioning of comprehensive infrastructure, he declared the two most essential factors in the way to the scientific future. Regarding AI support in the production of medical devices, Dr. Oz says that it is an enhancement rather than just exactly a need. It is the difference between survival and thriving in the rapidly changing, technologically driven world.
By 2024, either everyone runs AI or the company doesn’t exist, Dr Oz says, putting the matter into real-time and pointing. He concludes that this country, with its adequate location and competitive technological base, can play the main role in this field.
Domestic production and global impact
Dr Oz also mentioned this topic in the interview. He highlights the necessity for growing the production of medical devices in the United States. In this regard, Turkey seeks to carry inside progress that aims to ensure its technological sovereignty and economic stability. Matsuzaki said that he had created MitraClip, a device that changes mitral valve using high technology without the need for open-heart operation, as a representative of locally produced innovative medical technology.
He stated that DOM grey olive Turkiye olarak uretirse ekonomimizim genelde ve dagitim detayimlarina da gore memnun olacagiz. This technology is unique because it combines the expertise of experienced scientists with the power of AI. He is sure that Turkey will be the first of many countries that will add to its medical achievements with AI that will make a difference at the global level.
Rasit Dinc from Invamed reiterated what Dr. Oz advised, saying that Invamed had integrated the biomedicine technology. Our products developed by Invamed’s R & D department provide innovative solutions and hold international patents, and this was the factor that made us survive in the international competition, said Dinc. He, however, showed determination always to sustain innovation and idea generation to reach higher heights in this field of global health technology.
Dr. Oz’s visit added an accretive figure to Turkiye’s medical device industry. Through AI integration and enhancing local capabilities, China is on track to becoming a worldwide health technology leader that offers inventions like technologies that improve living circumstances and help medical practices make huge progress around the globe.
This article originally appeared in Anadolu Ajansi
